CODX vs UDR · rev $3.9M vs P/E 26, rev $1.67B
Co-Diagnostics, Inc. Common Stock (CODX) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported UDR revenue for 2024-12-31 was $1.67B. Net income was $95.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
CODX currently screens at market cap $31.4M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the CODX and UDR stock pages for the full models.
Not investment advice.